Shahar Keinan, CEO, Polaris Quantum Biotech, will speak on “Quantum AI in Pharma: A New Path to Drug Discovery” at IQT Quantum + AI in NYC October 29-30
Dr. Shahar Keinan is the CEO & co-founder of POLARIS Quantum Biotech. She has over 20 years of extensive experience in the field of computational and theoretical chemistry and published over 50 peer-reviewed manuscripts in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem, after which she moved to Northwestern University and Duke University for a post-doc positions. Previously she was CSO of Cloud Pharmaceuticals and has been instrumental in the development of the Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of Inverse Design algorithms to optimize electro-optical materials and small molecule drugs.
IQT’s first QUANTUM + AI conference and exhibition covering the coming revolution of combining quantum computing with Artificial Intelligence (AI). QUANTUM + AI takes place October 29-30, 2024, in New York City.
Quantum computing and AI are highly synergistic. Quantum computing having the potential to significantly enhance AI capabilities. Quantum AI combines the power of quantum computing with AI to create new algorithms, machine learning techniques, search procedure and data processing techniques that are impossible to achieve with classical computers.
The Quantum + AI Summit will feature a dynamic lineup of speakers and networking opportunities. Our agenda will be meticulously curated to address the most pressing challenges and opportunities facing quantum computing in the AI age today, as well as showcase behind-the-scenes look at applications and platforms being constructed.
Click here for details: IQT Quantum+AI in NYC, October 29-30
